First macro Monte Carlo based commercial dose calculation module for electron beam treatment planning--new issues for clinical consideration

Abstract

The purpose of this study is to present our experience of commissioning, testing and use of the first commercial macro Monte Carlo based dose calculation algorithm for electron beam treatment planning and to investigate new issues regarding dose reporting (dose-to-water versus dose-to-medium) as well as statistical uncertainties for the calculations arising when Monte Carlo based systems are used in patient dose calculations. All phantoms studied were obtained by CT scan. The calculated dose distributions and monitor units were validated against measurements with film and ionization chambers in phantoms containing two-dimensional (2D) and three-dimensional (3D) type low- and high-density inhomogeneities at different source-to-surface distances. Beam energies ranged from 6 to 18 MeV. New required experimental input data for commissioning are presented. The result of validation shows an excellent agreement between calculated and measured dose distributions. The calculated monitor units were within 2% of measured values except in the case of a 6 MeV beam and small cutout fields at extended SSDs (>110 cm). The investigation on the new issue of dose reporting demonstrates the differences up to 4% for lung and 12% for bone when 'dose-to-medium' is calculated and reported instead of 'dose-to-water' as done in a conventional system. The accuracy of the Monte Carlo calculation is shown to be clinically acceptable even for very complex 3D-type inhomogeneities. As Monte Carlo based treatment planning systems begin to enter clinical practice, new issues, such as dose reporting and statistical variations, may be clinically significant. Therefore it is imperative that a consistent approach to dose reporting is used.